Fact CheckerSign in

NCT06887413Recruiting

TACTIC Coronary Thrombus Aspiration With Cath Rx In Anterior Myocardial Infarction: A Randomized Control Trial.

Source: ClinicalTrials.gov · Last updated 21 Apr 2026

Brief summary (registry, in English)

The aim of this study is to evaluate the impact of sustained thrombectomy with INDIGO ASPIRATION SYSTEM using CAT RX versus no thrombectomy during primary percutaneous coronary intervention (PPCI) on microvascular obstruction and infarct size, as measured by cardiovascular magnetic resonance (CMR) between 3 and 5 days post PPCI, in patients with anterior STEMI

Status (registry)
Recruiting
Study type
Interventional
Enrollment
140 (estimated)
First submitted
4 Mar 2025
Start date
18 Feb 2026
Primary completion date
28 Feb 2027
Lead sponsor
Ceric Sàrl
NCT number
NCT06887413

What you commit to

  • Study type: Interventional
  • Planned participants: 140
  • From 18 Feb 2026 to the primary completion date, 28 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Unwitnessed cardiac arrest OR ≥30 minutes of cardiopulmonary resuscitation (CPR) prior to enrolment OR any cardiac arrest with impairment in mental status, cognition or any global or focal neurological deficit
  • New onset of stroke symptoms and NIHSS \>2, prior to index procedure
  • Administration of fibrinolytic therapy within 24 hours prior to enrolment
  • History or known hepatic insufficiency prior to catheterization
  • Undergoing a renal replacement therapy
  • Known or evidence of prior MI, including pathologic Q-waves in non-anterior leads
  • Prior coronary artery bypass graft surgery (CABG) or LAD PCI
  • History of heart failure (documented history of EF \<40% or documented hospitalization for HF within 1 year prior to screening
  • Prior aortic valve surgery or TAVR
  • History of stroke/TIA within 3 months prior to screening

Other illness

  • STEMI due to stent thrombosis
  • Active severe bleeding
  • Severe hepatic/kidney impairment
  • Inferior STEMI or suspected right ventricular failure
  • Acute cardiac mechanical complication: LV-free wall rupture OR interventricular septum rupture OR acute mitral regurgitation
    • Medical Conditions \& History:
  • Suspected systemic active infection
  • Chronic obstructive pulmonary disease (COPD) with home oxygen therapy or on chronic steroid therapy

Lab values

  • Cardiogenic shock defined as systemic hypotension (systolic BP \<90 mmHg or the need for inotropes/pressors to maintain a systolic BP \>90 mmHg), plus one (1) of the following: any requirement for pressors / inotropes prior to arrival at the catheterization laboratory, clinical evidence of end-organ hypoperfusion, or use of IABP or any other mechanical circulatory support device
  • Contraindication to perform MRI or use gadolinium \[creatinine clearance (CrCl) \<30 mL/min, non-compatible implant, claustrophobia\]
    • Cardiovascular history

Other

  • Unable to give Informed consent.
  • Life expectancy \< 1 year.
  • Contraindication to PCI
  • Spontaneous coronary aretery dissection
  • Patient undergone any kind of maneuvers to restore flow before randomization
  • Known intolerance to aspirin, clopidogrel, ticagrelor, heparin, contrast media.
  • Severe valvulopathy
  • Suspected or known pregnancy
  • Left bundle branch block (new or old)

Who the study is looking for

  • Age \>18 and \<75 years old
  • Acute anterior STEMI with ≥2 mm in two (2) or more contiguous anterior leads or ≥4 mm total ST-segment deviation sum in the anterior leads V1-V4 AND anterior wall motion abnormality noted on a diagnostic quality left ventriculogram or echocardiogram
  • Culprit lesion proximal or mid LAD at coronary angiography
  • TIMI thrombus grading \> 3 or TIMI flow 0 after guidewire crossing the lesion.
  • Patient presents to the hospital between 1 - 6 hours of ischemic pain onset
  • Patient indicated for primary percutaneous coronary intervention (PPCI)

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Ospedale San Raffaele
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.